SIM
PRNB

Spark Investment Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Spark Investment Management’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-9,392
Closed -$311K – 566
2019
Q2 		$311K Sell
9,392
-30,008
-76% -$937K 0.02% 419
2019
Q1 		$1.34M Buy
39,400
+31,400
+393% +$999K 0.06% 305
2018
Q4 		$219K Buy
+8,000
New +$206K 0.02% 490

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Spark Investment Management's PRNB Position: Q3 2019 in Review

Spark Investment Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2019, closing a stake of 9,392 shares — an estimated $311K sold.

Spark Investment Management first reported a position in PRNB in Q4 2018 and held it in 3 quarters. The position peaked at $1.34M in Q1 2019. 81 funds tracked by Wall St. Rank hold PRNB as of Q3 2019.

  • Spark Investment Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Spark Investment Management sold 9,392 Principia Biopharma Inc. Common Stock shares in Q3 2019, an estimated $311K.
  • Spark Investment Management first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 3 quarters.
  • Spark Investment Management's Principia Biopharma Inc. Common Stock position peaked at $1.34M in Q1 2019.
  • 81 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2019.

Based on Spark Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.